5-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione
C12H16O5 — CID 15277204
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione
5-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione (PubChem CID 15277204) has the molecular formula C12H16O5 and a molecular weight of 240.25 g/mol. Its IUPAC name is 5-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione.
Molecular Properties
| Compound Name | 5-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione |
|---|---|
| PubChem CID | 15277204 |
| Molecular Formula | C12H16O5 |
| Molecular Weight | 240.25 g/mol |
| Exact Mass | 240.10 |
| IUPAC Name | 5-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione |
| SMILES | CC1(C)OC(=O)C([C@H]2C=C[C@@H](CO)C2)C(=O)O1 |
| InChI | InChI=1S/C12H16O5/c1-12(2)16-10(14)9(11(15)17-12)8-4-3-7(5-8)6-13/h3-4,7-9,13H,5-6H2,1-2H3/t7-,8+/m1/s1 |
| InChIKey | PJDOMZXCGOXETQ-SFYZADRCSA-N |
| XLogP | 0.62 |
| TPSA | 72.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 17 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 240.25 |
| LogP ≤ 5 | 0.62 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15277204 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.